IL93754A - יחידה גנטית לעיכוב anr - Google Patents

יחידה גנטית לעיכוב anr

Info

Publication number
IL93754A
IL93754A IL9375490A IL9375490A IL93754A IL 93754 A IL93754 A IL 93754A IL 9375490 A IL9375490 A IL 9375490A IL 9375490 A IL9375490 A IL 9375490A IL 93754 A IL93754 A IL 93754A
Authority
IL
Israel
Prior art keywords
rna
dna
dna molecule
ribozyme
inhibiting
Prior art date
Application number
IL9375490A
Other languages
English (en)
Other versions
IL93754A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL93754A0 publication Critical patent/IL93754A0/xx
Publication of IL93754A publication Critical patent/IL93754A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9375490A 1989-03-16 1990-03-15 יחידה גנטית לעיכוב anr IL93754A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT60989 1989-03-16

Publications (2)

Publication Number Publication Date
IL93754A0 IL93754A0 (en) 1990-12-23
IL93754A true IL93754A (he) 1995-12-31

Family

ID=3495118

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9375490A IL93754A (he) 1989-03-16 1990-03-15 יחידה גנטית לעיכוב anr

Country Status (20)

Country Link
EP (1) EP0387775B1 (he)
JP (1) JP3330930B2 (he)
KR (1) KR900014591A (he)
AT (1) ATE140961T1 (he)
AU (1) AU637354B2 (he)
CA (1) CA2012312C (he)
DD (1) DD297838A5 (he)
DE (1) DE59010432D1 (he)
DK (1) DK0387775T3 (he)
ES (1) ES2090049T3 (he)
FI (1) FI105103B (he)
GR (1) GR3020935T3 (he)
HU (2) HU215187B (he)
IE (1) IE74850B1 (he)
IL (1) IL93754A (he)
NO (1) NO306623B1 (he)
NZ (1) NZ232917A (he)
PT (1) PT93440B (he)
RU (1) RU2136751C1 (he)
ZA (1) ZA901973B (he)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471796A4 (en) * 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
DE4091533T (he) * 1989-08-31 1992-01-30
JP2507895B2 (ja) * 1989-12-19 1996-06-19 工業技術院長 リボザイムの新規合成系
KR930701590A (ko) * 1990-06-19 1993-06-12 알프레드 퍼나트 엔도누클레아제
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
CA2093664C (en) * 1990-10-12 2003-07-29 Fritz Eckstein Modified ribozymes
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
FR2687411A1 (fr) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn.
WO1993022433A2 (de) * 1992-04-28 1993-11-11 Frank Andreas Harald Meyer Medikament zur gentherapeutischen behandlung von menschen, tieren und pflanzen, insbesondere zur blockierung der virenvermehrung und der tumorgene sowie verfahren zur herstellung des medikaments
JPH08502950A (ja) * 1992-05-14 1996-04-02 リボザイム・ファーマシューティカルズ・インコーポレイテッド 癌増殖を抑制する方法及び試薬
US5989906A (en) * 1992-05-14 1999-11-23 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
US5610052A (en) * 1992-08-26 1997-03-11 Ribozyme Pharmaceuticals Inc. Enzymatic RNA with activity to ras
EP0596901B1 (en) * 1992-05-27 2000-08-09 City Of Hope CHIMERIC tRNA LYS -RIBOZYME MOLECULES
US5827935A (en) * 1992-05-27 1998-10-27 City Of Hope Chimeric tRNAlys -ribozyme molecules
CA2137161C (en) * 1992-06-29 2007-09-18 David G. Atkins Nucleic acids and methods of use thereof for controlling viral pathogens
WO1994013798A1 (en) * 1992-12-16 1994-06-23 Bergmann Johanna E Agents for the prevention and treatment of human alzheimer's disease
DE69333216T2 (de) * 1993-07-06 2004-06-24 Université de Nice-Sophia Antipolis Vektor, enthält ein bei ARN-Polymerase-III transcriptes Virus-Gen
US5837503A (en) * 1993-07-07 1998-11-17 Universite De Nice-Sophia-Antipolis Vector containing viral gene transcribed by RNA polymerase III and methods for use
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
CA2157015A1 (en) * 1994-01-24 1995-07-27 John J. Rossi Inhibitors and target molecule co-localization
DE4424761C1 (de) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expressionskassette für die Antisense- und die Ribozym-Expression
JPH11506914A (ja) 1995-06-07 1999-06-22 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼーション 最適化ミニザイムおよびミニリボザイムおよびその使用
FR2755976B1 (fr) 1996-11-15 1999-01-15 Idm Immuno Designed Molecules Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
US6057156A (en) 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
WO1999020753A2 (en) * 1997-10-21 1999-04-29 Ribozyme Pharmaceuticals, Inc. Peptide bond formation using nucleic acid catalysts
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
KR20010042069A (ko) 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
AU776150B2 (en) 1999-01-28 2004-08-26 Medical College Of Georgia Research Institute, Inc. Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods

Also Published As

Publication number Publication date
CA2012312C (en) 2001-08-14
JPH03130080A (ja) 1991-06-03
DD297838A5 (de) 1992-01-23
IE74850B1 (en) 1997-08-13
ES2090049T3 (es) 1996-10-16
HU211868A9 (en) 1995-12-28
IL93754A0 (en) 1990-12-23
DE59010432D1 (de) 1996-09-05
PT93440A (pt) 1990-11-07
FI901296A0 (fi) 1990-03-15
NO901213D0 (no) 1990-03-15
NO306623B1 (no) 1999-11-29
EP0387775A1 (de) 1990-09-19
GR3020935T3 (en) 1996-12-31
NZ232917A (en) 1997-07-27
JP3330930B2 (ja) 2002-10-07
PT93440B (pt) 2001-07-31
RU2136751C1 (ru) 1999-09-10
NO901213L (no) 1990-09-17
HU901584D0 (en) 1990-06-28
ZA901973B (en) 1991-11-27
EP0387775B1 (de) 1996-07-31
ATE140961T1 (de) 1996-08-15
FI105103B (fi) 2000-06-15
IE900931L (en) 1990-09-16
CA2012312A1 (en) 1990-09-16
AU637354B2 (en) 1993-05-27
DK0387775T3 (da) 1996-11-04
HUT54206A (en) 1991-01-28
AU5130190A (en) 1990-11-01
HU215187B (hu) 1998-10-28
KR900014591A (ko) 1990-10-24

Similar Documents

Publication Publication Date Title
CA2012312C (en) Genetic units for inhibiting the function of rna
JP3316216B2 (ja) 安定化外部ガイド配列
US5792645A (en) Protein-polycation nucleic acid complexes and methods of use
US5874414A (en) Trans-splicing ribozymes
US5989906A (en) Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
US5667969A (en) Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing
US5750390A (en) Method and reagent for treatment of diseases caused by expression of the bcl-2 gene
CA2135499A1 (en) Method and reagent for inhibiting cancer development
JPH10500309A (ja) リボザイムを用いて再狭窄および癌を治療するための方法および組成物
US6183959B1 (en) Method for target site selection and discovery
CA2148368A1 (en) Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes
US5599704A (en) ErbB2/neu targeted ribozymes
US6830923B1 (en) Genetics units for inhibiting the function of RNA
US20040072783A1 (en) Nucleozymes with endonuclease activity
Phylactou et al. Utilization of properties of natural catalytic RNA to design and synthesize functional ribozymes
Qiu Cellular ribonucleases and the design of hammerhead ribozymes
IE83273B1 (en) New protein-polycation-conjugates

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired